A Certificate of Analysis (COA) is a detailed document that discloses the chemical profile and safety characteristics of a specific batch of cannabis product. This essential report ensures transparency and compliance in the regulated cannabis industry by verifying that the product is safe, consistently manufactured, and meets stringent quality standards. High Performance Liquid Chromatography (HPLC) is commonly employed to analyze cannabinoids, terpenes, and contaminants.
All Rove products are lab tested multiple times throughout the production process including a final state mandated compliance test which undergoes 7 phases of testing for: Microbials • Mycotoxins • Pesticides • Cannabinoids • Heavy Metals • Foreign Materials • Residual Solvents
Test Results Report
Result Totals
-
Total active cannabinoids
95.37%
The sum of cannabinoids present in a cannabis sample that have psychoactive or therapeutic effects.
-
Total THC
90.06%
Total amount of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in cannabis.
-
Total CBD
0%
Total amount of cannabidiol, a non-intoxicating cannabinoid known for its potential therapeutic effects.
Tests Performed
Cannabinoids
- ND means that the compound was not detected in lab testing. <LOQ means that the compound was able to be detected in such a small amount that an accurate measurement could not be made.
-
CBD
ND
CBD, or Cannabidiol, is typically the second-most abundant cannabinoid in cannabis, but this isn’t always the case. High-CBD strains tend to deliver very clear-headed, functional effects without the euphoric high associated with high-THC strains. They’re typically preferred by consumers who are extremely sensitive to the side effects of THC (e.g., anxiety, paranoia, dizziness). A high-CBD strain would also be a great choice for someone needing to medicate throughout the day to control pain, inflammation, anxiety, or other chronic conditions.